Solel Partners’s CVS Health CVS Stock Holding History

Solel Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.5M	Sell	493,700 -100,000	-17%	-$7.7M	7.58%	5
2025 Q4	$47.1M	Sell	593,700 -120,000	-17%	-$9.46M	7.62%	3
2025 Q3	$53.8M	Buy	713,700 +39,400	+6%	+$2.7M	10.35%	3
2025 Q2	$46.5M	Sell	674,300 -100,000	-13%	-$6.56M	8.1%	5
2025 Q1	$52.5M	Sell	774,300 -650,100	-46%	-$38.9M	9.71%	3
2024 Q4	$63.9M	Buy	1,424,400 +295,500	+26%	+$16.6M	12.52%	2
2024 Q3	$71M	Buy	1,128,900 +625,500	+124%	+$36.5M	13.93%	1
2024 Q2	$29.7M	Buy	+503,400	New	+$31.5M	4.84%	12

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Solel Partners's CVS Position: Q1 2026 in Review

Solel Partners reduced its CVS Health (CVS) stake by 17% in Q1 2026, selling an estimated $7.7M and leaving 493,700 shares worth $35.5M. The position accounts for 7.58% of the portfolio, ranked #5.

Solel Partners first reported a position in CVS in Q2 2024 and has held it in 8 quarters since. The position peaked at $71M in Q3 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Solel Partners held 493,700 shares of CVS Health worth $35.5M as of Q1 2026.
Solel Partners sold 100,000 CVS Health shares in Q1 2026, an estimated $7.7M.
CVS Health made up 7.58% of Solel Partners's portfolio in Q1 2026, its #5 holding.
Solel Partners first reported a position in CVS Health in Q2 2024 and has held it in 8 quarters since.
Solel Partners's CVS Health position peaked at $71M in Q3 2024.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Solel Partners's 13F filing for Q1 2026, filed 15 May 2026.